von Schoultz B - Search Results

1

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.

Kenemans P, Bundred NJ, Foidart JM, Kubista E, von Schoultz B, Sismondi P, Vassilopoulou-Sellin R, Yip CH, Egberts J, Mol-Arts M, Mulder R, van Os S, Beckmann MW; LIBERATE Study Group. Kenemans P, et al. Among authors: von schoultz b. Lancet Oncol. 2009 Feb;10(2):135-46. doi: 10.1016/S1470-2045(08)70341-3. Epub 2009 Jan 23. Lancet Oncol. 2009. PMID: 19167925 Free article. Clinical Trial.

2

Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density.

Lundström E, Bygdeson M, Svane G, Azavedo E, von Schoultz B. Lundström E, et al. Among authors: von schoultz b. Climacteric. 2007 Jun;10(3):249-56. doi: 10.1080/13697130701385805. Climacteric. 2007. PMID: 17487652 Clinical Trial.

3

Testosterone addition during menopausal hormone therapy: effects on mammographic breast density.

Hofling M, Lundström E, Azavedo E, Svane G, Hirschberg AL, von Schoultz B. Hofling M, et al. Among authors: von schoultz b. Climacteric. 2007 Apr;10(2):155-63. doi: 10.1080/13697130701258812. Climacteric. 2007. PMID: 17453864 Clinical Trial.

4

Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women.

Nathorst-Böös J, Wiklund I, Mattsson LA, Sandin K, von Schoultz B. Nathorst-Böös J, et al. Among authors: von schoultz b. Acta Obstet Gynecol Scand. 1993 Nov;72(8):656-60. doi: 10.3109/00016349309021160. Acta Obstet Gynecol Scand. 1993. PMID: 8259754 Clinical Trial.

5

Transdermally administered oestradiol combined with oral medroxyprogesterone acetate: the effects on lipoprotein metabolism in postmenopausal women.

Mattsson LA, Samsioe G, von Schoultz B, Uvebrant M, Wiklund I. Mattsson LA, et al. Among authors: von schoultz b. Br J Obstet Gynaecol. 1993 May;100(5):450-3. doi: 10.1111/j.1471-0528.1993.tb15270.x. Br J Obstet Gynaecol. 1993. PMID: 8518245 Clinical Trial.

6

Expression of Syndecan-1 in histologically normal breast tissue from postmenopausal women with breast cancer according to mammographic density.

Lundström E, Sahlin L, Skoog L, Hägerström T, Svane G, Azavedo E, Sandelin K, von Schoultz B. Lundström E, et al. Among authors: von schoultz b. Climacteric. 2006 Aug;9(4):277-82. doi: 10.1080/13697130600865741. Climacteric. 2006. PMID: 16857657

7

A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolon and continuous combined estrogen-progestogen treatment.

Conner P, Christow A, Kersemaekers W, Söderqvist G, Skoog L, Carlström K, Tani E, Mol-Arts M, von Schoultz B. Conner P, et al. Among authors: von schoultz b. Climacteric. 2004 Mar;7(1):50-8. doi: 10.1080/13697130310001651472. Climacteric. 2004. PMID: 15259283 Clinical Trial.

8

The effects of tibolone and oestrogen-based HT on breast cell proliferation and mammographic density.

von Schoultz B. von Schoultz B. Maturitas. 2004 Sep 24;49(1):S16-21. doi: 10.1016/j.maturitas.2004.06.011. Maturitas. 2004. PMID: 15351103 Review.

9

HRT and breast cancer risk, what to advise?

von Schoultz B. von Schoultz B. Eur J Obstet Gynecol Reprod Biol. 1997 Feb;71(2):205-8. doi: 10.1016/s0301-2115(96)02636-x. Eur J Obstet Gynecol Reprod Biol. 1997. PMID: 9138967 Review.

10

Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.

von Schoultz B. von Schoultz B. Climacteric. 2003 Aug;6 Suppl 2:24-32. Climacteric. 2003. PMID: 14669841 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters